14F7 in chronic B-cell lymphoproliferative syndrome |
Bioequivalence of Trienor |
Bioequivalence of Efavirenz |
Bioequivalence of Zidovudine |
Bioequivalence of Sildenafil |
Bioequivalence of Phenytoin |
Bioequivalence of Diltiazem retard |
Bioequivalence of Digoxin |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
Bioequivalence of Clopidogrel |
Chitosan Unguent in burned patients |
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
Bioequivalence of diclofenac sodium retard |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
Bioequivalence of Abacavir |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
Bioactive formulation to treat osteoarthritis |
Homeostec for chronic arthritis |
Phenamate in the treatment of prostate cancer |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |